Table 4.
ErbB-2 Status | DFS |
OS |
||||
---|---|---|---|---|---|---|
% | 95% CI | % | 95% CI | |||
All ErbB-2 high | 62 | 52 to 73 | 71 | 61 to 81 | ||
All ErbB-2 low | 49 | 42 to 56 | 56 | 49 to 63 | ||
ErbB-2 high/P-ErbB-2− | 59 | 46 to 76 | 69 | 56 to 85 | ||
ErbB-2 high/P-ErbB-2+ | 60 | 44 to 80 | 66 | 51 to 86 | ||
ErbB-2 low/P-ErbB-2− | 51 | 45 to 59 | 58 | 52 to 66 | ||
ErbB-2 low/P-ErbB-2+ | 25 | 6 to 83 | 42 | 16 to 100 | ||
All P-ErbB-2 negative | 53 | 47 to 60 | 60 | 54 to 67 | ||
All P-ErbB-2 positive | 52 | 39 to 71 | 60 | 46 to 80 | ||
FISH positive | 48 | 38 to 60 | 51 | 41 to 63 | ||
FISH negative | 53 | 48 to 59 | 61 | 56 to 66 |
Abbreviations: DFS, disease-free survival; OS, overall survival; CAF, cyclophosphamide, doxorubicin, and fluorouracil.